Physician compensation rises alongside burnout, retirements in 2021
Over 73% of physicians reported feeling overworked amid the pandemic and 50% said they are considering an employment change because of it, Doximity’s annual report found.
3 medtech markets poised to thrive in 2022 despite renewed COVID-19 pressures
While the emergence of the omicron variant is muddying next year’s medtech outlook, analysts have identified three niches within the sector best positioned to successfully weather the continued strains on the healthcare system.
FDA finds 3 COVID-19 tests that fail to detect the omicron variant
Diagnostics from Applied DNA Sciences, Meridian Bioscience and Tide Laboratories are not able to detect omicron, causing false negative results, and should not be used, the agency said.
Intermountain, SCL Health move forward with merger plans
The two health systems are planning to create an $11 billion system, led by Marc Harrison, Intermountain’s current CEO.
Federal COVID-19 aid fueled huge jump in national health spending last year
The pandemic accounted for major changes in who paid for healthcare as job losses spurred changes in coverage types, while people deferred care and spent less out of their own pockets.
Huge variance in state costs for complex hospitalizations from COVID-19, analysis finds
New Jersey has the highest in-network costs for complex hospitalizations from COVID-19 of any U.S. state, nonprofit Fair Health said. Maryland, which uses an all-payer model, had the lowest.
HHS to funnel $9B in relief funds to providers
The federal government will reimburse smaller providers more favorably in this funding round, regulators said, acknowledging these facilities tend to operate on shakier financial footing compared to larger peers.
Coronavirus variants are accelerating front-line worker burnout to new heights
While physicians said chaotic work environments are to blame for their burnout, nurses cited after-hours workloads, according to a recent report from KLAS Research’s Arch Collaborative.
Humana sues slate of drugmakers, alleging anticompetitive practices to protect HIV drug monopoly
The payer filed suit Monday against Gilead, Teva, Janssen and Bristol Myers Squibb, alleging the drugmakers conspired to protect the market dominance of lucrative HIV medications despite the existence of generic alternatives.
Neidorff to retire as Centene, activist investor group agree to board shakeup
The longtime CEO is now set to be replaced by the end of next year, and a new policy mandates a board retirement age of 75.